GeneBioTech Co. Ltd
Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food, medicine, etc. It offers functional feed ingredients and additives, as well as veterinary medicines. The company was founded in 1984 and is headquartered in Gongju, South Korea.
GeneBioTech Co. Ltd (086060) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.072x
Based on the latest financial reports, GeneBioTech Co. Ltd (086060) has a cash flow conversion efficiency ratio of 0.072x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.87 Billion) by net assets (₩54.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GeneBioTech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how GeneBioTech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GeneBioTech Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GeneBioTech Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BBIA Co., Ltd.
KQ:451250
|
0.004x |
|
Pioneer Bankshares Inc
PINK:PNBI
|
0.032x |
|
Voltaic Minerals Corp
V:VLT
|
-0.134x |
|
China HK Power Smart Energy Group Limited
OTCGREY:CHNTF
|
N/A |
|
Anli International Co Ltd
TWO:5223
|
-0.017x |
|
Wotso
AU:WOT
|
0.034x |
|
Habco Trans Maritima
JK:HATM
|
0.017x |
|
Earlyworks Co., Ltd. American Depositary Shares
NASDAQ:ELWS
|
-1.245x |
Annual Cash Flow Conversion Efficiency for GeneBioTech Co. Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of GeneBioTech Co. Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩50.97 Billion | ₩-463.87 Million | -0.009x | -105.97% |
| 2023-12-31 | ₩48.30 Billion | ₩7.37 Billion | 0.153x | +289.60% |
| 2022-12-31 | ₩45.73 Billion | ₩-3.68 Billion | -0.080x | -24.45% |
| 2021-12-31 | ₩43.95 Billion | ₩-2.84 Billion | -0.065x | -216.88% |
| 2020-12-31 | ₩45.04 Billion | ₩2.49 Billion | 0.055x | +196.80% |
| 2019-12-31 | ₩46.93 Billion | ₩-2.68 Billion | -0.057x | -146.02% |
| 2018-12-31 | ₩47.96 Billion | ₩5.96 Billion | 0.124x | +343.93% |
| 2017-12-31 | ₩40.49 Billion | ₩1.13 Billion | 0.028x | -79.46% |
| 2016-12-31 | ₩39.02 Billion | ₩5.31 Billion | 0.136x | +50.66% |
| 2015-12-31 | ₩28.84 Billion | ₩2.61 Billion | 0.090x | -1.78% |
| 2014-12-31 | ₩23.42 Billion | ₩2.15 Billion | 0.092x | -10.63% |
| 2013-12-31 | ₩23.10 Billion | ₩2.38 Billion | 0.103x | -20.67% |
| 2011-12-31 | ₩19.48 Billion | ₩2.53 Billion | 0.130x | +104.69% |
| 2010-12-31 | ₩18.38 Billion | ₩1.17 Billion | 0.063x | -57.24% |
| 2009-12-31 | ₩18.08 Billion | ₩2.68 Billion | 0.148x | -- |